Insulin doses before and one year after pump start: Children have a reversed dawn phenomenon

Journal of Diabetes Science and Technology

Volumn 6, Issue 3, 2012, Pages 589-594

  Nicolajsen, Tom ^a   Samuelsson, Andreas ^b   Hanas, Ragnar ^a  

^a NU Hospital Group   (Sweden)

^b Department of Surgery NU Hospital Group ^*  (Sweden)

Author keywords

Basal rate; Bolus doses; Children; Dawn phenomenon; Diabetes; Insulin pump

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BASAL METABOLIC RATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; MORNING HYPERGLYCEMIA; RETROSPECTIVE STUDY; TIME TO TREATMENT; TREATMENT DURATION; AGE; BLOOD; CIRCADIAN RHYTHM; DOSE CALCULATION; DRUG EFFECT; INSULIN INFUSION; METABOLISM; PRESCHOOL CHILD; TIME; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CIRCADIAN RHYTHM; DIABETES MELLITUS; DRUG DOSAGE CALCULATIONS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879724625     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600314     Document Type: Article

References (30)

1. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics. 2001;107(2):351-6. (Pubitemid 32121252)
2. McMahon SK, Airey FL, Marangou DA, McElwee KJ, Carne CL, Clarey AJ, Davis EA, Jones TW. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med. 2005;22(1):92-6. (Pubitemid 40188293)
3. Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4-year follow-up. Diabet Med. 2006;23(8):900-6. (Pubitemid 44141080)
4. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes. 2002;3(1):10-5. (Pubitemid 34618799)
5. Samuelsson U. Data from the Swedish National Pediatric Diabetes Register (SWEDIABKIDS) 2010. Diabetolognytt 2011;24 (Suppl):1-77.
6. Pańkowska E, Błazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes. 2009;10(1):52-8.
7. Danne T, von Schutz W, Lange K, Nestoris C, Datz N, Kordonouri O. Current practice of insulin pump therapy in children and adolescents - the Hannover recipe. Pediatr Diabetes. 2006;7 Suppl 4:25-31. (Pubitemid 44122711)
8. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22(11):1779-84. (Pubitemid 29521861)
9. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr. 2002;141(4):490-5. (Pubitemid 35193313)
10. Doyle EA, Weinzimer SA, Stefen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the eficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care. 2004;27(7):1554-8. (Pubitemid 38857425)
11. Carroll MF, Schade DS. The dawn phenomenon revisited: implications for diabetes therapy. Endocr Pract. 2005;11(1):55-64. (Pubitemid 43073091)
12. Edge JA, Matthews DR, Dunger DB. The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol (Oxf). 1990;33(6):729-37.
13. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia. 1990;33(1):52-9. (Pubitemid 20035474)
14. Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW; German/Austrian DPV Initiative; German Pediatric CSII Working Group; BMBF Competence Network Diabetes. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) difer for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes. 2012;13(1):1-5.
15. Klinkert C, Bachran R, Heidtmann B, Grabert M, Holl RW; DPV-Initiative. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes. 2008;116(2):118-22. (Pubitemid 351363382)
16. Wizemann E, Renner R, Hepp K. Prospective evaluation of a standardized basal rate distribution for CSII in type 1 diabetes over 6 months. Diabetologie Stofwechsel. 2001;10:57.
17. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabetes Res Clin Pract. 2005;69(1):14-21. (Pubitemid 40813408)
18. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM; IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004;50(1):166-74. (Pubitemid 38125714)
19. Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr. 2002;140(2):235-40. (Pubitemid 34183665)
20. DiMeglio LA, Boyd SR, Pottorf TM, Cleveland JL, Fineberg N, Eugster EA. Preschoolers are not miniature adolescents: a comparison of insulin pump doses in two groups of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2004;17(6):865-70. (Pubitemid 38997090)
21. Shashaj B, Sulli N. Diference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment. Diabetes Technol Ther. 2009;11(12):767-74.
22. Danne T, Battelino T, Kordonouri O, Hanas R, Klinkert C, Ludvigsson J, Barrio R, Aebi C, Gschwend S, Mullis PE, Schumacher U, Zumsteg U, Morandi A, Rabbone I, Cherubini V, Toni S, de Beaufort C, Hindmarsh P, Sumner A, van Waarde WM, van den Berg N, Phillip M. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes. 2005;6(4):193-8. (Pubitemid 43013626)
23. Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2009;10(1):33-7.
24. Dantas RO, Aben-Athar CG. [Aspects of sleep efects on the digestive tract]. Arq Gastroenterol. 2002;39(1):55-9.
25. Ross JJ, Agnew HW Jr, Williams RL, Webb WB. Sleep patterns in preadolescent children: an EEG-EOG study. Pediatrics. 1968;42(2):324-35.
26. Bolli GB, Perriello G, Fanelli CG, De Feo P. Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care. 1993;16 Suppl 3:71-89. (Pubitemid 23348323)
27. Yagasaki H, Kobayashi K, Saitou T, Nagamine K, Mitsui Y, Mochizuki M, Kobayashi K, Cho H, Ohyama K, Amemiya S, Nakazawa S. Nocturnal blood glucose and IGFBP-1 changes in type 1 diabetes: Diferences in the dawn phenomenon between insulin regimens. Exp Clin Endocrinol Diabetes. 2010;118(3):195-9.
28. Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L. Melatonin and serotonin efects on gastrointestinal motility. J Physiol Pharmacol. 2007;58 Suppl 6:97-103.
29. Ardura J, Gutierrez R, Andres J, Agapito T. Emergence and evolution of the circadian rhythm of melatonin in children. Horm Res. 2003;59(2):66-72. (Pubitemid 36206663)
30. Ardura-Fernandez J, Andres De Llano JM, Garmendia-Leiza JR, Agapito T. Melatonin rhythm in children with enuresis. BJU Int. 2007;99(2):413-5. (Pubitemid 46103127)